“…In the past, several body composition parameters have been examined, with contradicting results regarding their prognostic relevance. This was most likely due to heterogeneity of study populations, methods employed to analyze the data, cut‐offs used and clinical settings examined 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 Sarcopenia—a term used for low muscle mass—was associated with frailty, immobility and worse overall survival (OS) in PDAC patients. 8 , 9 , 10 , 11 , 15 , 16 , 17 , 18 , 20 , 22 The combination of sarcopenia with obesity (sarcopenic obesity) or visceral obesity (sarcopenic visceral obesity) demonstrated potential prognostic relevance in other types of cancer.…”